Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Aerovance is a privately held biopharmaceutical company exclusively focused on developing and commercializing breakthrough medicines for respiratory and allergic diseases. The company maintains a solid intellectual property position with its strong portfolio of novel therapeutic candidates now in clinical development and several pre-clinical programs. The two lead products are human recombinant proteins: Aerovantâ„¢, an IL-4 and -13 receptor antagonist which is in Phase IIa studies for asthma and Aerodermâ„¢, a PEGylated IL-4 and IL-13 receptor antagonist in pre-clinical studies for eczema.

Yungjin Pharm. Co., Ltd. engages in the development, production, and distribution of pharmaceuticals. Its products include cephalosporin, antibiotics, drugs for the central nervous system, cardiovascular, endocrine system, urinary system, respiratory, anti-inflammatory and analgesics, anti-histamine, anti-fungal, total nutrition, vitamin and supplement, cosmetics, and tonic drinks. The company was founded on July 16, 19672 and is headquartered in Seoul, South Korea.

Uwm Research Foundation, Inc. is an American private company located in Milwaukee, WI. The firm operates as a research foundation.

Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain.

Antisense Therapeutics is a biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.

Dong-A Pharmaceutical Co., Ltd., a subsidiary of Dong-A Socio Holdings Co., Ltd., is a company headquartered in Seoul, the South Korea, that manufactures drug products.

Cryptopharma Pty Ltd. develops novel anti-inflammatory therapeutic agents for the treatment of pulmonary diseases. It focuses on the development of CP92, a treatment of Cystic Fibrosis. The company was founded by Alastair George Stewart and John Lambert in October 2000 and is headquartered in Victoria, Australia.

Navipharm Co. Ltd. is a Vietnamese private company located in Dong Da dist that manufactures pharmaceuticals products.

ProThera Biologics was established in the state of Rhode Island in 2001 by Yow-Pin Lim, MD/PhD, Assistant Professor of Medicine, Brown Medical School and Douglas C. Hixson, PhD, Professor of Medicine and Pathology/ Laboratory Medicine, Brown Medical School. Both co-founders are actively engaged in the biomedical research in the Carcinogenesis Laboratory at Rhode Island Hospital, where Dr. Hixson is the longstanding Research Director and Dr. Lim is a Research Oncologist.

Defensin Therapeutics ApS

Chang Gung Biotechnology is a Taiwanese private company located in Taipei that manufactures and retails herbal & dietary supplements.

Beijing Shuobai Pharmaceutical Technology Co., Ltd., established on 2016-10-14, Business scope includes technology promotion,technology development,technology transfer,technical consulting,Technical Services;Sales of chemical products(Free of Hazardous Chemicals).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policy of the district.)

Beijing Fengshuo Weikang Technology Development Co., Ltd., established on 2001-01-15, Business scope includes pharmaceutical technology,Technical development of chemical products and medical technology,technology transfer,technical consulting,Technical Training,Technical Services;Information Consulting(Except intermediary);Advertising Design,make;Corporate Image Planning;Organize cultural exchange activities;Organize exhibitions and demonstrations;Sales of chemical products(Free of Hazardous Chemicals).(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policy of the district.)

MD Healthcare, Inc. is engaged in developing innovative precision medical solutions based on micro biome data. The company was founded in January, 2014 and is headquartered in Seoul, South Korea.